Insta
Chinese COVID-19 Vaccine Candidate's Final-Stage Trial Halted In Brazil After 'Serious Adverse Event'
Swarajya Staff
Nov 10, 2020, 08:49 AM | Updated 08:49 AM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a major setback for a potential Chinese COVID-19 vaccine candidate developed by Sinovac Biotech Limited, the vaccine's final-stage trial has been halted in Brazil due to a serious adverse event, reports Hindustan Times.
The adverse event occurred on 29 October and marks the first such instance when one of the Chinese vaccines has met with a setback. Meanwhile, Brazilian health Agency has not given out any further details of the illness caused by the vaccine candidate, called Coronavac.
The Agency is now evaluating if it should continue with the study.
While such adverse events during drug trials could include death, immediate risk of death, long term or serious health implications or hospitalisation, it should be noted that such events are not uncommon in large-scale drug trials.
Recently, AstraZeneca Plc and Johnson & Johnson had also paused their vaccine trials due to serious adverse events, only to re-start them after investigation.
However, in China's case, the nation has already begun administering the vaccines, including the Coronavac, to hundreds of thousands of people, causing worry.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.